Soo J. Yoon
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Diverse Clinical Phenotypes of Neuronal Intranuclear Inclusion Disease in South Korea.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: November 29, 2024
Semantic variant primary progressive aphasia with ANXA11 p.D40G.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 29, 2024
South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trial.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 08, 2024
Association between osteoporosis and the rate of telomere shortening.
Journal: Aging
Published: February 20, 2024
Effect of Dietary Habits on Alzheimer's Disease Progression.
Journal: Yonsei medical journal
Published: April 28, 2023
Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related Phenotypes.
Journal: JAMA network open
Published: December 15, 2022
Predicting cognitive stage transition using p-tau181, Centiloid, and other measures.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 13, 2022
The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer's disease.
Journal: Clinical biochemistry
Published: November 15, 2022
Genetic Screening in Korean Patients with Frontotemporal Dementia Syndrome.
Journal: Journal of Alzheimer's disease reports
Published: May 05, 2022
Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism.
Journal: Journal of clinical medicine
Published: April 04, 2022
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).
Journal: Journal of Alzheimer's disease : JAD
Published: March 11, 2022
Last Updated: 09/26/2026